High Content Screening: Science, Techniques and Applications / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $130.25
Usually ships in 1-2 business days
(Save 21%)
Other sellers (Hardcover)
  • All (8) from $130.25   
  • New (5) from $130.25   
  • Used (3) from $130.25   

Overview

The authoritative reference on High Content Screening (HCS) in biological and pharmaceutical research, this guide covers: the basics of HCS: examples of HCS used in biological applications and early drug discovery, emphasizing oncology and neuroscience; the use of HCS across the drug development pipeline; and data management, data analysis, and systems biology, with guidelines for using large datasets. With an accompanying CD-ROM, this is the premier reference on HCS for researchers, lab managers, and graduate students.

Read More Show Less

Product Details

  • ISBN-13: 9780470039991
  • Publisher: Wiley
  • Publication date: 1/9/2008
  • Edition number: 1
  • Pages: 448
  • Product dimensions: 6.48 (w) x 9.37 (h) x 1.16 (d)

Meet the Author

Steven A. Haney, PhD, is a Principal Scientist in the Department of Biological Technologies at Wyeth Research, where he has developed programs for oncology drug development, built a HCS program for use in target validation and drug discovery, and prepared gene family-based target validation strategies. Dr. Haney has authored many peer-reviewed articles and has spoken at numerous conferences on HCS.

Read More Show Less

Read an Excerpt

Click to read or download

Read More Show Less

Table of Contents

Preface.

Contributors.

SECTION I: ESSENTIALS OF HIGH CONTENT SCREENING.

1. Approaching High Content Screening and Analysis: Practical Advice for Users (Scott Keefer and Joseph Zock).

1.1 Introduction.

1.2 What is HCS and Why Should I Care?

1.3 How does HCS Compare with Current Assay Methods?

1.4 The Basic Requirements to implement HCS.

1.5 The Process.

1.6 An Example Approach.

1.7 Six Considerations for HCS Assays.

References.

2. Automated High Content Screening Microscopy (Paul A. Johnston).

2.1 Introduction.

2.2 Automated HCS Imaging Requirements.

2.3 Components of Automated Imaging Platforms.

2.4 Imaging Platform Software.

2.5 Data Storage and Management.

2.6 Selecting an HCS Platform.

2.7 Comparison of a SAPK Activation HCS Assay Read on an ArrayScanw 3.1, an ArrayScanw VTi, and an IN Cell 3000 Automated Imaging Platform.

References.

3. A Primer on Image Informatics of High Content Screening (Xiaobo Zhou and Stephen T.C. Wong).

3.1 Background.

3.2 HCS Image Processing.

3.3 Validation.

3.4 Information System Management.

3.5 Data Modeling.

3.6 Conclusions.

3.7 Acknowledgements.

References.

4. Developing Robust High Content Assays (Arijit Chakravarty, Douglas Bowman, Jeffrey A. Ecsedy, Claudia Rabino, John Donovan, Natalie D’Amore, Ole Petter Veiby, Mark Rolfe, and Sudeshna Das).

4.1 Introduction.

4.2 Overview of a Typical Immunofluorescence-Based High Content Assay.

4.3 Identifying Sources of Variability in a High Content Assay.

4.4 From Immunofluorescence to High Content: Selecting the Right Metric.

4.5 Validation of High Content Assays.

4.6 Conclusion.

4.7 Acknowledgements.

References.

SECTION II: APPLICATIONS OF HCS IN BASIC SCIENCE AND EARLY DRUG DISCOVERY.

5. HCS in Cellular Oncology and Tumor Biology (Steven A. Haney, Jing Zhang, Jing Pan, and Peter LaPan).

5.1 Cancer Cell Biology and HCS.

5.2 The Cell Biology of Cell Death.

5.3 Cell Signaling Pathways in Cancer.

5.4 HCS in Tumor Biology.

5.5 Conclusions.

References.

6. Exploring the Full Power of Combining High Throughput RNAi with High Content Readouts: From Target Discovery Screens to Drug Modifier Studies (Christoph Sachse, Cornelia Weiss-Haljiti, Christian Holz, Kathrin Regener, Francoise Halley, Michael Hannus, Corina Frenzel, Sindy Kluge, Mark Hewitson, Benjamin Bader, Amy Burd, Louise Perkins, Alexander Szewczak, Stefan Prechtl, Claudia Merz, Peter Rae, Dominik Mumberg, and Christophe J. Echeverri).

6.1 Background: The Convergence of High Content Analysis and RNAi.

6.2 Integrating HT-RNAi and HCA in Drug Discovery: The Potential.

6.3 Combining RNAi and HCA in one Assay — the Reality.

6.4 HCA-Based RNAi Studies — The Future.

6.5 Acknowledgements.

References.

7. Leveraging HCS in Neuroscience Drug Discovery (Myles Fennell, Beal McIlvain, and John Dunlop).

7.1 High Content Screening and Drug Discovery.

7.2 The Neuron and Neuronal Morphology.

7.3 Methods for Measuring Neuronal Morphology.

7.4 Small Molecule Screening for Neurite Outgrowth.

7.5 RNAi in Neuroscience and HCA.

7.6 Measurement of Signal Transduction in Neurons.

7.7 High Content Screening in Complex CNS Models.

7.8 Methods used in Neuronal HCS.

References.

8. Live Brain Slice Imaging for Ultra High Content Screening: Automated Fluorescent Microscopy to Study Neurodegenerative Diseases (O. Joseph Trask, Jr., C. Todd DeMarco, Denise Dunn, Thomas G. Gainer, Joshua Eudailey, and Donald C. Lo).

8.1 Introduction and Background.

8.2 Live Brain Slice Model to Study Huntington’s Disease.

8.3 Imaging Platforms.

8.4 Center of Well (COW) for Image Processing.

8.5 Generic Protocol for the Cellomics ArrayScan VTI.

8.6 Data and Results.

8.7 Discussion.

References.

9. High Content Analysis of Human Embryonic Stem Cell Growth and Differentiation (Paul J. Sammak, Vivek Abraham, Richik Ghosh, Jeff Haskins, Esther Jane, Patti Petrosko, Teresa M. Erb, Tia N. Kinney, Christopher Jefferys, Mukund Desai, and Rami Mangoubi).

9.1 Introduction.

9.2 Cell Culture Methods.

9.3 Statistical Wavelet Analysis for Stem Cell Classification.

9.4 Molecular Analysis of Pluripotency and Cell Proliferation in Undifferentiated Stem Cells.

9.5 Analysis of Cardiomyocyte Differentiation.

9.6 Analysis of Neuronal Differentiation.

References.

SECTION III: HCS IN DRUG DEVELOPMENT.

10. HCS for HTS (Ann F. Hoffman and Ralph J. Garippa).

10.1 Introduction.

10.2 HCS for Orphan GPCRS and Transfluor.

10.3 HCS for Multiparameter Cytotoxicity Screening.

10.4 Discussion.

10.5 Summary.

References.

11. The Roles of High Content Cellular Imaging in Lead Optimization (Jonathan A. Lee, Karen Cox, Aidas Kriauciunas, and Shaoyou Chu).

11.1 Introduction.

11.2 Statistical Validation of Assays.

11.3 High Content Cellular Imaging is a Diverse Assay Platform.

11.4 Use of High Content Cellular Imaging For Oncology Research at Eli Lilly.

11.5 The Future of High Content Cellular Imaging in Lead Optimization.

11.6 Acknowledgements.

References.

12. Using High Content Analysis for Pharmacodynamic Assays in Tissue (Arijit Chakravarty, Douglas Bowman, Kristine Burke, Bradley Stringer, Barbara Hibner, and Katherine Galvin).

12.1 Introduction.

12.2 Designing a High Content Assay for Use in Tissues.

12.3 Technical Challenges in Establishing High Content Assays for Tissue.

12.4 Case Study: Design and Validation of a High Content Assay for Biomarker X.

12.5 Conclusions.

12.6 Acknowledgements.

References.

13. High Content Analysis of Sublethal Cytotoxicity in Human HepG2 Hepatocytes for Assessing Potential and Mechanism for Chemicaland Drug-Induced Human Toxicity (Peter J. O’Brien).

13.1 Introduction.

13.2 Results from High Content Analysis of Human Toxicity Potential.

13.3 Discussion.

13.4 Acknowledgements.

13.5 Appendix: Detailed Methods.

References.

SECTION IV: DATA MANAGEMENT, DATA ANALYSIS AND SYSTEMS BIOLOGY.

14. Open File Formats for High Content Analysis (Jason R. Swedlow, Curtis Rueden, Jean-Marie Burel, Melissa Linkert, Brian Loranger, Chris Allan, and Kevin W. Eliceiri).

14.1 Introduction.

14.2 The Data Problem in Biology: Why is it so Hard?

14.3 High Content Data in Biology: A Definition.

14.4 The difference Between a File Format and a Minimum Specification.

14.5 File Formats: Open vs Closed.

14.6 File Formats: Balancing Flexibility with Standards.

14.7 Supporting a Successful File Format.

14.8 Commercial Realities: How Users and Developers can Define File Formats.

14.9 OME-ML and OME-TIFF: Moving Towards a Standard Format For High Content Biological Data.

14.10 Data Model and File Format Integration: Towards Usable Tools.

14.11 Conclusions.

14.12 Acknowledgements.

References.

15. Analysis of Multiparametric HCS Data (Andrew Hill, Peter LaPan, Yizheng Li, and Steven A. Haney).

15.1 Cytological Classification and Profiling.

15.2 Setting Up Cytological Profiling Studies.

15.3 Sources of Variability and Corrections.

15.4 General Analysis Considerations.

15.5 Data Analysis Methods.

15.6 Software for HCS Data Analysis.

15.7 Conclusions.

References.

16. Quantitative and Qualitative Cellular Genomics: High Content Analysis as an Endpoint for HT-RNAi Phenotype Profiling Using GE’s InCell Platform (David O. Azorsa, Christian Beaudry, Kandavel Shanmugam, and Spyro Mousses).

16.1 Cellular Genomics.

16.2 Enabling Technologies to Facilitate Cellular Genomics: RNA Interference.

16.3 High Throughput Rnai (HT-RNAi).

16.4 High Content Analysis (HCA) for High Throughput Phenotype Profiling.

16.5 Future Directions.

References.

17. Optimal Characteristics of Protein–Protein Interaction Biosensors for Cellular Systems Biology Profiling (Kenneth A. Giuliano, David Premkumar, and D. Lansing Taylor).

17.1 Introduction.

17.2 Challenge of Cellular Systems Biology (CSB).

17.3 Optimal Characteristics of Protein–Protein Interaction Biosensors (PPIBs).

17.4 Example of a PPIB and Cellular Systems Biology Profiling.

17.5 Summary and Prospects.

17.6 Acknowledgements.

References.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)